Hot Features
プレミアム
OptimizeRx Corporation (OPRX)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Ms. Theresa GrecoChief Commercial Officer | -1.79k | 9.34k | Sale to Issuer | 5.21 | 32.60k | -5.21% |
| 2026-05-15 | Mr. Stephen L. SilvestroCEO & Director | -5.22k | 27.19k | Sale to Issuer | 5.21 | 110.76k | -4.50% |
| 2026-02-11 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | 2.61k | 0.00 | Derivative Exercise and Retained Stock | - | 48.71k | 5.67% |
| 2026-02-11 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -1.39k | 12.79k | Derivative Exercise and Sale | 9.23 | 48.71k | - |
| 2025-12-23 | Mr. Stephen L. SilvestroCEO & Director | -3.36k | 42.82k | Sale to Issuer | 12.74 | 100.33k | -3.24% |
| 2025-12-23 | Ms. Theresa GrecoChief Commercial Officer | -1.42k | 18.09k | Sale to Issuer | 12.74 | 31.24k | -4.35% |
| 2025-12-23 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -4.05k | 51.61k | Sale to Issuer | 12.74 | 46.09k | -8.08% |
| 2025-12-23 | Mr. Edward StelmakhChief Financial & Strategic Officer | -3.66k | 46.60k | Sale to Issuer | 12.74 | 79.94k | -4.38% |
| 2025-12-23 | Dr. Doug BeschChief Product Officer & CTO | -4.08k | 51.97k | Sale to Issuer | 12.74 | 23.65k | -14.71% |
| 2025-12-19 | Mr. Edward StelmakhChief Financial & Strategic Officer | 3.85k | 0.00 | Derivative Exercise and Retained Stock | - | 69.80k | 5.84% |
| 2025-12-19 | Mr. Edward StelmakhChief Financial & Strategic Officer | -1.39k | 18.75k | Derivative Exercise and Sale | 13.51 | 69.80k | - |
| 2025-12-19 | Mr. Stephen L. SilvestroCEO & Director | 4.95k | 0.00 | Derivative Exercise and Retained Stock | - | 89.89k | 5.83% |
| 2025-12-19 | Mr. Stephen L. SilvestroCEO & Director | -1.59k | 21.53k | Derivative Exercise and Sale | 13.51 | 89.89k | - |
| 2025-12-19 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | 2.78k | 0.00 | Derivative Exercise and Retained Stock | - | 36.34k | 8.27% |
| 2025-12-19 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -1.15k | 15.58k | Derivative Exercise and Sale | 13.51 | 36.34k | - |
| 2025-12-19 | Mr. Brendan MerrellCOO | -289.00 | 3.90k | Sale to Issuer | 13.51 | 9.96k | -2.82% |
| 2025-12-19 | Mr. Andrew Jacob D'SilvaChief Business Officer | -703.00 | 9.50k | Sale to Issuer | 13.51 | 21.19k | -3.21% |
| 2025-12-19 | Dr. Doug BeschChief Product Officer & CTO | 1.38k | 0.00 | Derivative Exercise and Retained Stock | - | 13.92k | 11.03% |
| 2025-12-19 | Dr. Doug BeschChief Product Officer & CTO | -581.00 | 7.85k | Derivative Exercise and Sale | 13.51 | 13.92k | - |
| 2025-12-11 | Mr. Brendan MerrellCOO | -712.00 | 9.99k | Sale to Issuer | 14.03 | 9.27k | -7.14% |
| 2025-12-11 | Mr. Andrew Jacob D'SilvaChief Business Officer | -868.00 | 12.18k | Sale to Issuer | 14.03 | 19.93k | -4.17% |
| 2025-10-03 | Mr. Brendan MerrellCOO | -483.00 | 9.06k | Sale to Issuer | 18.75 | 7.55k | -6.01% |
| 2025-10-01 | Mr. Andrew Jacob D'SilvaChief Business Officer | -1.21k | 22.75k | Sale to Issuer | 18.75 - 18.98 | 18.37k | -6.17% |
| 2025-11-01 | Ms. Theresa GrecoChief Commercial Officer | -1.69k | 34.69k | Sale to Issuer | 20.49 | 27.48k | -5.80% |
| 2025-10-03 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | 4.70k | 0.00 | Derivative Exercise and Retained Stock | - | 33.57k | 16.27% |
| 2025-10-03 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -1.95k | 36.60k | Derivative Exercise and Sale | 18.75 | 33.57k | - |
| 2025-10-03 | Mr. Edward StelmakhChief Financial & Strategic Officer | 12.22k | 0.00 | Derivative Exercise and Retained Stock | - | 65.95k | 22.74% |
| 2025-10-03 | Mr. Edward StelmakhChief Financial & Strategic Officer | -4.41k | 82.61k | Derivative Exercise and Sale | 18.75 | 65.95k | - |
| 2025-10-03 | Mr. Stephen L. SilvestroCEO & Director | 5.03k | 0.00 | Derivative Exercise and Retained Stock | - | 84.94k | 6.29% |
| 2025-10-03 | Mr. Stephen L. SilvestroCEO & Director | -1.62k | 30.38k | Derivative Exercise and Sale | 18.75 | 84.94k | - |
| 2025-10-03 | Dr. Doug BeschChief Product Officer & CTO | -983.00 | 18.43k | Derivative Exercise and Sale | 18.75 | 12.54k | - |
| 2025-10-03 | Dr. Doug BeschChief Product Officer & CTO | 2.34k | 0.00 | Derivative Exercise and Retained Stock | - | 12.54k | 22.97% |
| 2025-08-28 | Mr. Patrick D. SpanglerIndependent Director | -11.12k | 194.49k | 売り | 17.49 | 34.35k | -24.46% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
